yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q35238074-875F498F-573E-42A6-A015-3ED9022CE540
Q35238074-875F498F-573E-42A6-A015-3ED9022CE540
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35238074-875F498F-573E-42A6-A015-3ED9022CE540
Ranibizumab for macular edema secondary to retinal vein occlusion: a meta-analysis of dose effects and comparison with no anti-VEGF treatment.
P2860
Q35238074-875F498F-573E-42A6-A015-3ED9022CE540
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35238074-875F498F-573E-42A6-A015-3ED9022CE540
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5c2134b2ae17c451da23d44110cdd36e4679eea7
P2860
The burden of disease of retinal vein occlusion: review of the literature.